BlueDot logo — BlueDot empowers public and private organizations to identif...

BlueDot

BlueDot empowers public and private organizations to identify, anticipate, and respond to infectious disease threats.

Founded 2013 Canada Toronto, Canada 95 employees Grant Total: $14.84M AI, Analytics +2

General Information

Company Name BlueDot
Founded Year 2013
Location Canada Toronto, Canada
Employees 95
Industries AI, Analytics, Big Data +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with BlueDot. To contact BlueDot, visit bluedot.global.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BlueDot compare?

A PDF of BlueDot and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BlueDot soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BlueDot

BlueDot, a Toronto-based infectious disease intelligence company, is revolutionizing the way we respond to infectious disease risk. Using a unique combination of human and artificial intelligence, BlueDot has developed a groundbreaking global early warning technology for infectious diseases. Their outbreak risk platform is capable of tracking over 120 infectious diseases globally in 65 languages, delivering around-the-clock insights and anticipating their spread and impact. The company's mission is to empower national and international health agencies, pharmaceutical and life sciences companies, and businesses to proactively anticipate and respond to emerging threats. BlueDot gained global recognition for being among the first to identify the risk from the COVID-19 pandemic, and they continue to provide critical insights to partners and customers to mobilize timely and effective responses. Founded in 2013 by Dr. Kamran Khan, a practicing infectious disease physician and Professor of Medicine at the University of Toronto, BlueDot is driven by a deep commitment to leveraging 15 years of research on infectious disease outbreaks. Their last investment of $3.00M in grant funding on 11 January 2023 from the Government of Canada further cemented their position as a leading force in the fight against infectious diseases. BlueDot operates at the intersection of analytics, big data, and healthcare, making significant strides in proactive disease surveillance and response. With its innovative approach and esteemed founder, BlueDot is well-positioned to continue making a meaningful impact in the global health landscape.

Business keywords: Infectious Disease Intelligence, Global Early Warning Technology, Human Intelligence, Public Health, Epidemiology, Disease Tracking, Pandemic Response, Health Crisis Management

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.00M 1
Government of Canada
11 Jan 2023
Series A $9.20M 5
Golden Ventures, Horizons Ventures +3
07 Aug 2019
Series A $2.10M 1
Horizons Ventures
13 Jan 2015
Grant $140.00K 1
Ontario Centres of Excellence
15 Sep 2013
Seed Round $400.00K 2
MaRS IAF, Toronto Innovation Acceleration Partners
15 Sep 2013

BlueDot Alternatives & Competitors

View All Alternatives
BlueDot vs
HSR.health
HSR.health United States

Exclusive health data analytics with actionable insights

18 employees
Analytics, Health Care
BlueDot vs
Biobot Analytics
Biobot Analytics United States

Public health analytics powered by wastewater. MIT spin-off / Y Combinator W18

Grant
31 employees
Analytics, Big Data
BlueDot vs

Automated sampling of pathogens for improved global health security

9 employees
AI, Automation

FAQ About BlueDot

BlueDot empowers public and private organizations to identify, anticipate, and respond to infectious disease threats.
BlueDot was founded in 2013.
BlueDot is headquartered in Toronto, Canada.
BlueDot operates in AI, Analytics, Big Data and Health Care. Its work centres on Infectious Disease Intelligence, Global Early Warning Technology, Human Intelligence and Public Health.
BlueDot has approximately 95 employees.
BlueDot has completed 5 funding rounds, raising a total of $14.84M. The latest funding stage is Grant.
Top alternatives and competitors to BlueDot include HSR.health, Biobot Analytics, Lifeline Robotics, iklim.co, Gnowit Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BlueDot and HSR.health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BlueDot, https://bouncewatch.com/company/bluedot-2, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes